glp 1 agonisti GLP-1 Receptor Agonists: The New Wave in Diabetes Management GLP-1 and Anesthesia: Considerations and

Nearly one in five GLP-1 users say they are taking a compounded or custom-mixed version of the drugs, with the lower cost fueling a shift away from brand-name versions, Gallup's Witters writes

The Precision Peptide Genetic Test reveals predispositions in pathways including FTO rs9939609, MC4R rs17782313, GIPR rs1800437, and GLP1R rs6923761markers that may provide broader context about metabolic regulation and tissue remodeling capacity

Metseras recent announcement of positive Phase 2b data for MET-097i a First- and Best-in-Class Ultra-long Acting GLP-1 RA candidate marks an important step forward, with Phase 3 expected to begin in 2025

Molecules 25, 5763